Sugemalimab, a fully human, full-length anti-PD-L1 immunoglobulin G4 (IgG4) monoclonal antibody (mAb), has been investigated in a Single-Arm, Multicenter, Phase II Study (GEMSTONE-201). The results demonstrated significant efficacy, favorable tolerability, and manageable adverse reactions of ...
24,99 €/ 30 days cancel any time Learn more Buy this article Purchase on SpringerLink Instant access to full article PDF Buy now Additional access options: Log in Learn about institutional subscriptions Read our FAQs Contact customer support ...
Check access to the full text by signing in through your organization. Access through your organization Section snippets PD1 within the tumor microenvironment It is now appreciated that tumors usually contain specialized immunosuppressive microenvironments that enable disease development and progression. Th...
Compared with control cells overexpressing full-length CETN1-eGFP, the basal body remained in the apical area of cone cells overexpressing CETN1(101–172)-eGFP, while the LD was further away from the basal body (Figures 5C and 5D). Therefore, overexpression of CETN1(101–172)-eGFP disturbs...
Full size image Detection of PD-L1 in Circulating Tumor Cells and Patient Tissues PD-L1 expression in patient tissues was analyzed using RK-10-Cy5 and compared to expression in MDA-MB-231 cells and a negative control of normal blood (Fig.5). The MFI of the MDA-MB-231 cells was 9,448...
Figure 22 shows the differences between DQ2 and DQ6 in graphical form. The remaining scenario is that the system initially determines that the toggle bit is toggling and DQ5 has not gone high. The system may continue to monitor the toggle bit and DQ5 through successive read cycles, determining...
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content? Obtain permissions instantly via Rightslink by clicking on the button below: Request Academic Permissions If you are unable to obtain permissions via Rightsl...
.submit-customize-form-section,#bannerCOVID,#textContainer,#cust_button,button#c_banner_subsrible_btn,/*.fixed-customize-form button,.btm-txt,input#frm_phone_code,input#frm_phone_number,div#fixedform-loader,.most-popular-plan,div#price-selection-wrapper-new,.price-container .price-wrapper ....
Full size image We further introduced GANT61, an inhibitor of Gli1 [25,26]. By establishing an orthotopic syngeneic model of HCC using Hepa1-6 cells, we systemically administered GANT61 and an anti-PDL1 monoclonal antibody (mAb) (Fig.7D). Our results indeed confirmed the efficacy of the ...